Abstract
A number of yeast fungi are pathogenic, but the two genera that contain the most important animal pathogens are Candida and Cryptococcus. In addition, there are a number of other yeasts that have been, more rarely, implicated in disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beck-Sague CM, Jarvis WR (1993) National nosocomial infection surveillance system. Secular trends in the epidemiology of fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251.
Bottone E, Wormser G (1992) Capsule-defieient crypto- cocci in AIDS. Lancet 2:553
Buckley RH (1992) Immunodeficiency diseases. JAMA 268:2797–2806
Chuck SL, Sande MA (1989) Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 321:794–799
Crislip MA, Edwards JE (1989) Candidiasis. Infect Dis Clin N Am 3:103–182
Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA (1989) Itraconazole therapy for crptococcal meningitis and cryptococcosis. Arch Int Med 149: 2301–2308
Dismukes W (1988) Cryptococcal meningitis in patients with AIDS. J Infect Dis 157:624–628
Dixon DM, Folak-Wyss A (1991) The medically important dematiaceous fungi and their identification. Mycoses 34:1–18
Gueho E, Guillot J (1994) Taxonomy and phylogeny of Malassezia and Trichosporon, Program and Abstracts of the 12th Congr of The International Society for Human and Animal Mycology, Adelaide, South Australia, March 1994, S29.1, p D31
Just-Nubling G, Gentschew G, Dohle M, Bottinger C, Helm EB, Stille W (1990) Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. Mycoses 33:435–440
Kappe R, Levitz SM, Cassone A, Washburn RG (1992) Mechanisms of host defense against funal infection. J Med Vet Mycol 30(Suppl 1): 167–177
Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH (1984) Oral candidasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311:354 – 358
Klotz S (1989) Malassezia furfur. Infect Dis Clin N Am 3:53–64
Kovacs J, Kovacs A, Polis M, Wright W, Gelmann E, Lane H, Lonfield R, Overturf G, Mâcher A, Fauci A, Parrillo J, Bennett J, Masur H (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Int Med 103:533–538
Kwon-Chung KJ, Bennett JE (1992) Medical mycology. Lea Febiger, Philadelphia
Lalor E, Rabeneck L (1991) Esophageal candidiasis in AIDS. Dig Dis Sci 36:270–281
Larsen RA, Leal MAE, Chan LS (1990) Fluconazole compared with amphotericin B plus flucytosine for crytococcal meningitis in AIDS. A randomized trial. Ann Int Med 113:183–187
Lecciones JA, Lee JW, Navarro E, Witebsky FG, Marshall DJ, Steinberg SM, Pizzo PA, Walsh TJ (1992) Vascular catheter-associated fungemia in cancer patients: analysis of 155 episodes. Rev Infect Dis 14:875–883
Leggiadro R, Kline M, Hughes W (1991) Extrapulmonary cryptococcosis in children with AIDS. Pediatr Inf Dis J 10:658–662
Lyman C, Walsh TJ (1992) Systemically administered antifungal agents: a review of clinical pharmacology and therapeutic applications. Drugs 44:9–35
Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP (1984) Systemic candidiasis in cancer patients. Am J Med 77(4D):20–27
McCarthy GM (1992) Host factors associated with HIV- related oral candidiasis. Oral Med Oral Pathol 73: 181–186
Nathwani D, Green St, McGuire W, Goldberg DJ, Kennedy DH (1989) New triazoles antifungal agents (fluconazole and intraconazole) in the treatment of HIV-related gastrointestinal candidiasis. Scand J Infect Dis 21:355–356
Odds FC (1992) Candida infections in AIDS. Int J STD Aids 3:157–160
Powderly WG, Saag MS, Cloud GA, Robinson P, Meyer RD, Jacobson JM, Graybill JR, Sugar AM, McAullife VJ, Follansbee SE (1992) A controlled trial of fluconazole or amphotericin B to prevent relapse of crypto-coccal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 326:793–798
Redline R, Reline S, Boxerbaum B (1985) Systemic Malassezia furfur infections in patients receiving intra-lipid therapy. Hum Pathol 16:815
Roy MJ, Walsh TJ (1992) Histopathological and immuno-histochemical changes in gut-associated lympoid tissues following treatment of rabbits with dexamethasone. Lab Invest 64:437–443
Viviani MA (1992) Opporunistic fungal infections in patients with acquired immune deficiency syndrome. Chemotherapy 38(Suppl):35–42
Walsh TJ, Melcher GP, Lee JW, Pizzo PA (1993) Infections due to Trichosporon species: new concepts in mycology, pathogenesis, diagnosis, and treatment. Curr Top Med Mycol 5:79–113
Walsh TJ, Hier DB, Caplan LR (1985) Fungal infections of the central nervous system: analysis of risk factors and clinical manifestations. Neurology 35: 1654–1657
Zuger A, Louie E, Holzman R, Simberkoff M, Rhal J (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Int Med 104: 234–240
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Walsh, T.J. (1996). Yeast Infections in the Immunocompromised Host. In: Howard, D.H., Miller, J.D. (eds) Human and Animal Relationships. The Mycota, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10373-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-10373-9_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-10375-3
Online ISBN: 978-3-662-10373-9
eBook Packages: Springer Book Archive